Is Petros Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PTPI) stock is to Strong Buy PTPI stock.
Out of 1 analyst, 1 (100%) are recommending PTPI as a Strong Buy, 0 (0%) are recommending PTPI as a Buy, 0 (0%) are recommending PTPI as a Hold, 0 (0%) are recommending PTPI as a Sell, and 0 (0%) are recommending PTPI as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year PTPI price target, the average PTPI price target is $4.00, with the highest PTPI stock price forecast at $4.00 and the lowest PTPI stock price forecast at $4.00.
The Wall Street analyst predicted that Petros Pharmaceuticals's share price could reach $4.00 by Dec 8, 2024. The average Petros Pharmaceuticals stock price prediction forecasts a potential upside of 515.38% from the current PTPI share price of $0.65.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.